Mark Kleven

Chief Operations Officer at Neurolixis - Wilmington, DE, us

Mark Kleven's Colleagues at Neurolixis
Chuck Agree

senior scientist, medicinal chemistry

Contact Chuck Agree

Fabienne Herbrecht

Director of Clinical Development

Contact Fabienne Herbrecht

Mark Kleven's Contact Details
HQ
N/A
Location
Greater Boston
Company
Neurolixis
Mark Kleven's Company Details
Neurolixis logo, Neurolixis contact details

Neurolixis

Wilmington, DE, us • 5 - 9 Employees
Major Drugs

Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including Parkinson's disease, Rett syndrome, depression and schizophrenia.Neurolixis advances the clinical development of in-licensed clinical-phase drugs as well as identifying novel chemical entities. Neurolixis actively pursues collaborations and has been awarded grants by Parkinson's UK, the Michael J. Fox Foundation, Parkinson's UK, the International Rett Syndrome Foundation and the Rett Syndrome Research Trust.

Pharmaceuticals
Details about Neurolixis
Frequently Asked Questions about Mark Kleven
Mark Kleven currently works for Neurolixis.
Mark Kleven's role at Neurolixis is Chief Operations Officer.
Mark Kleven's email address is ***@neurolixis.com. To view Mark Kleven's full email address, please signup to ConnectPlex.
Mark Kleven works in the Major Drugs industry.
Mark Kleven's colleagues at Neurolixis are Chuck Agree, Fabienne Herbrecht and others.
Mark Kleven's phone number is N/A
See more information about Mark Kleven